Related Experiment Videos
[Macrolide resistance in Mycoplasma pneumoniae by recurrence and extended illness]
Søren Anker Uldum1, Paul Amberg, Jørgen Skov Jensen
1Afdeling for Mikrobiologisk Diagnostik og Forskning, Statens Serum Institut, Artillerivej 5, 2300 København S, Denmark. su@ssi.dk
A 36 year-old female with a Mycoplasma pneumoniae (MP) infection was treated with azithromycin. She recovered transitory, but experienced a relapse a few days later. After ten days she visited her general practitioner again; she was tired and weakened, had a debilitating dry cough and a weight loss of 6 kg. A throat swab was positive for MP by a polymerase chain reaction (PCR). It was investigated by sequencing and a mutation corresponding to a A2063G transition in domain V of the 23S rRNA known to be associated with macrolide resistance was detected. Twenty-two days later, MP could still be detected by PCR on a nasopharyngeal secretion.
A 36 year-old female with a Mycoplasma pneumoniae (MP) infection was treated with azithromycin. She recovered transitory, but experienced a relapse a few days later. After ten days she visited her general practitioner again; she was tired and weakened, had a debilitating dry cough and a weight loss of 6 kg. A throat swab was positive for MP by a polymerase chain reaction (PCR). It was investigated by sequencing and a mutation corresponding to a A2063G transition in domain V of the 23S rRNA known to be associated with macrolide resistance was detected. Twenty-two days later, MP could still be detected by PCR on a nasopharyngeal secretion.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Atypical Pneumonia
Clinical Significance of Antibiotic Resistance
Pneumonia II: Pathophysiology
Development of Antibiotic Resistance
Pneumonia I: Introduction